热门资讯> 正文

MannKind首席执行官购买10万股;股价攀升

2026-03-11 22:00

曼恩凯德生物医疗(MNKD) 0

MannKind(MNKD) chief executive officer and director, Michael Castagna reported buying 100,000 shares of company stock.
The shares were purchased on March 10, 2026, at a price of $2.59 per share.
The transaction increased Castagna’s direct ownership to 2.58M shares.
MNKD shares up 7.7%.

More on MannKind

Furoscix Growth Versus Tyvaso Royalties: Assessing MannKind's Future
MannKind Corporation 2025 Q4 - Results - Earnings Call Presentation
MannKind Corporation (MNKD) Q4 2025 Earnings Call Transcript
MannKind outlines $450M 2026 revenue run rate and key product catalysts amid Afrezza pediatric launch preparations
MannKind hits 52-week low after Q4 earnings miss

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。